News
Three Faculty Elected to American Academy of Arts and Sciences
UC San Francisco cancer biologist Alan Ashworth, PhD, structural biologist Yifan Cheng, PhD, and molecular physiologist Holly Ingraham, PhD, have been elected to the American Academy of Arts and Sciences. Ashworth is president of the UCSF Helen Diller Family Comprehensive Cancer Center and E. Dixon
Training and Mentoring the Next Generation of Cancer Researchers and Providers
Led by Dr. Emily Bergsland, Associate Director of Education for the Helen Diller Family Comprehensive Cancer Center, the Office of Education & Training (OET) aims to connect the UCSF cancer community with education, mentoring, and career development opportunities across all trainee levels. We sat
UCSF Study Aims to Increase Diversity in Cancer Clinical Trials
UC San Francisco is collaborating with the nonprofit Lazarex Cancer Foundation on a three-year study to identify ways to improve cancer clinical trial participation among medically underserved populations, including low-income individuals and racial and ethnic minorities. The trial will launch this
Medicaid Could Save $2.6 Billion Within a Year if Just 1 Percent of Recipients Quit Smoking
Reducing smoking, and its associated health effects, among Medicaid recipients in each state by just 1 percent would result in $2.6 billion in total Medicaid savings the following year, according to new research by UC San Francisco. The median state would save $25 million, ranging from $630.2
Researchers Identify a New Therapeutic Target for Glioblastoma and Other Cancers
UCSF researchers have discovered that STAG2 – a gene commonly mutated in several human cancers – plays an essential role in DNA replication, revealing potential mechanisms for therapeutically targeting glioblastoma and other cancers. As part of a multi-protein complex called cohesin, the STAG2
Cancer-Killing Combination Therapies Unveiled with New Drug-Screening Tool
UC San Francisco scientists have designed a large-scale screen that efficiently identifies drugs that are potent cancer-killers when combined, but only weakly effective when used alone. Using this technique, the researchers eradicated a devastating blood cancer and certain solid tumor cells by
Sarah J. Nelson, PhD (1954-2019)
from Christopher P. Hess, MD, PhD Professor and Chair, Department of Radiology and Biomedical Imaging UCSF It is with a very heavy heart that I share with you that Sarah J. Nelson, PhD, luminary imaging scientist, friend, and long-time faculty member in the UCSF Department of Radiology and